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The mechanism by which vagal nerve stimulation (VNS) exerts an anticonvulsant effect in humans is unknown. This study used
99mTc-HMPAO single photon emission tomography (SPECT) to examine the effects of VNS on regional cerebral activity in
thalamic and insular regions.
Seven subjects with epilepsy who had been receiving vagal nerve stimulation for at least 6 months underwent SPECT scanning
with simultaneous scalp electroencephalographic (EEG) recording. Subjects were studied in two states; during VNS activity
and during a comparison condition of VNS inactivity.
A region of interest analysis demonstrated that rapid cycling stimulation (7 seconds on, 12 seconds off) was associated with
relatively decreased activity in left and right medial thalamic regions. No systematic stimulation-related changes were observed
on visual or spectral analysis of EEG data.
The thalamus is involved in modulation of ongoing cortical EEG activity in animals. Our results support the hypothesis that
VNS may exert an antiepileptic action by an effect on thalamic activity.
c© 2000 BEA Trading Ltd
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INTRODUCTION
Short-term randomized controlled trials1 and longer-
term open follow-up2 have indicated that vagal
nerve stimulation (VNS) is an effective treatment in
some patients with intractable epilepsy. Currently, the
mechanism by which VNS exerts an anticonvulsant
effect is unknown3. However, it is known that ascend-
ing pathways from the nucleus solitarius (the prin-
cipal afferent nucleus of the vagus nerve) project to
regions of the cerebral cortex, hypothalamus and
thalamus involved with the generation of rhythmic
electroencephalographic (EEG) activity4, 5. Investiga-
tions in rats have suggested that VNS may directly
lead to local changes in brain activity, although the
direction of these changes varies in different brain
areas. A study of VNS-induced fos expression demon-
strated increased fos in the thalamic habenular
nuclei, cingulate gyrus and amygdala6. (Fos is a pro-
tein released from neurones under conditions of high
neuronal activity.) On the other hand, reductions of
glucose metabolism in the hypothalamus, frontal and
parietal cortices and the nucleus solitarius have been
considered to indicate that VNS in rats causes inhi-
bition in these structures7. Given that the nucleus soli-
tarius is a site of termination of vagal afferents, Walker
et al.8 have examined the effects of direct modulation
of GABA and glutamate in this region, by the admin-
istration of GABA agonists, antagonists and a gluta-
mate agonist, on induced seizures. They observed that
both GABA agonist activity and glutamate antagonism
in the mediocaudal nucleus solitarius led to seizure
protection. The authors concluded that, in rats, en-
hancing GABA transmission or inhibiting glutamate
transmission reduced susceptibility to limbic motor
seizures, suggesting that VNS-induced inhibition of
nucleus solitarius outputs may enhance seizure resis-
tance.
In humans with epilepsy there have been no changes
detected in inter-ictal EEG during VNS. However,
blood flow imaging investigations in patients under-
going VNS have suggested that stimulation-related
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changes in brain activity may be observed. The aim of
the current study was to use single photon emission
tomography (SPECT) blood-flow imaging (measuring
99mTc-HMPAO uptake), combined with simultane-
ous scalp EEG recording, to further investigate the
functional cerebral correlates of VNS in patients with
epilepsy.
MATERIALS AND METHODS
(i) Study design: A ‘split-dose’ SPECT activation de-
sign was employed consisting of two separate tracer
injections, each followed by a scan, all performed
within one experimental session lasting just over an
hour. The 5 minutes surrounding (1 minute before and
4 minutes following) each tracer injection constituted
the two experimental periods during which EEG data
were recorded. Subjects were scanned in two states;
during VNS rapid-cycling activity and during a com-
parison condition in which VNS was not active. The
order of experimental and comparison conditions was
blindly alternated between patients.
(ii) Subjects: Seven patients with chronic treatment-
resistant epilepsy were studied. All had been im-
planted with a vagus nerve stimulator at the Royal
London Hospital at least 6 months prior to the study.
The study was approved by the local Research Ethics
Committee and all subjects gave written informed
consent.
(iii) VNS stimulation details: All subjects received
stimulation at 30 Hz with a pulse width of 500 mi-
croseconds. During the active condition, stimulation
was delivered in a ‘rapid-cycling’ fashion with a signal
ON-time of 7 seconds alternating with a signal OFF-
time of 12 seconds. During the comparison condition,
subjects received no stimulation. During stimulation,
output current was within the range 0.5–2.0 mA, hav-
ing been clinically determined for each subject as the
optimum current during the preceding months of treat-
ment.
(iv) Imaging details: The blood flow tracer 99mTc-
HMPAO was employed. It was freshly prepared
immediately before injection in each of the two
scans. Administered activity in each injection was
285 MBq. The camera used was a triple-headed brain-
dedicated IGE Neurocam with general purpose colli-
mators, giving an in-plane reconstructed image reso-
lution (FWHM) at the centre of the field of view of
10.9 mm9. During injection of tracer, subjects sat qui-
etly looking at a plain wall. Subjects were repositioned
for the second scan with the aid of placement marks
drawn on the scalp.
(v) Image analysis: Image analysis was performed
using the Hermes Multimodality image analysis pack-
age (Nuclear Diagnostics Ltd, Kent, UK). Compar-
ison and experimental scans were corrected, within
each individual, to the maximum counts in the sec-
ond scan. Following correction, comparison and ex-
perimental scans were analysed, blind to scan con-
dition, using a region of interest (ROI) approach. In
each subject, freely drawn ROIs were simultaneously
placed on matching slices from the two scans. Place-
ment of ROIs was guided by comparison of the ob-
tained SPECT images with equivalent slices from an
atlas of human brain anatomy10. The regions studied
were left and right medial thalamus, left and right tha-
lamic pulvinars, left and right anterior insula regions
and a bilateral occipital region. Comparison and ex-
perimental results were compared using repeated mea-
sures ANOVA.
(vi) EEG methodology: EEG electrodes were ap-
plied according to the 10–20 electrode placement sys-
tem. Right and left superficial sphenoidal electrodes
were also used for each recording. The ON/OFF cycle
of the vagal nerve stimulator was monitored by plac-
ing two electrodes on the left side of the neck, one on
each side of the scar caused by the implantation of the
vagal nerve stimulator. During the recordings the sub-
jects were awake and alert with their eyes open.
To analyse the EEG a Fast Fourier Transform was
used on consecutive ON and OFF periods within the
rapid-cycling paradigm. In six patients the EEG was
also recorded with the stimulator completely OFF.
To compare these periods of EEG data a Wilcoxon
matched-pairs signed-rank analysis was used. Visual
analysis of the EEG was also performed comparing
the ON and OFF periods during rapid cycling.
RESULTS
(i) Clinical variables
Seven patients were studied and are described in Ta-
ble 1. It can be seen that whilst two patients derived
no benefit from VNS, three others experienced at least
a 50% reduction in seizure frequency. The remaining
two patients noted some improvement, both with re-
spect to reduction in seizure frequency (by 24% in
one case and by 30% in the other) and with respect
to reduction in seizure severity and quicker recovery
to full consciousness and activity after the ictus. Using
a non-parametric Wilcoxon pair-wise comparison, it is
found that overall the group demonstrated a significant
reduction in seizure frequency following initiation of
VNS (P = 0.046).
(ii) EEG findings
(a) Results of visual analysis: No difference in the
EEG was seen by visual inspection between the
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Table 1: Descriptions of the patients studied.
Age (years) Duration of Seizures Seizures Duration of VNS Drug treatment Seizure type
epilepsy (years) per month per month (months)
before VNS with VNS
36 5 12 8 8 cbz cps-gen
19 11 8 9 8 cbz cps-gen
19 13 >100 >100 15 cbz svp cps-gen
dph gp
23 19 50 38 6 cbz svp cps-gen
dph
35 5 160 80 6 svp l cps-gen
60 16 7 3 13 cbz t cps-gen
28 22 10 5 11 cbz v cps-gen
VNS = vagal nerve stimulation; cbz = carbamazepine; svp = sodium valproate; dph = phenytoin; gp = gabapentin; l = lamotrigine; t =
topiramate; v = vigabatrin; cps-gen = complex partial seizures with secondary generalization.
ON and OFF periods of rapid cycling
(b) Results of EEG quantitative analysis, in seven
patients, comparing the ON and OFF periods
during rapid cycling: Within individuals statisti-
cally significant results (P < 0.05) were found
at a number of electrodes for absolute and rela-
tive power and median frequency covering all
frequency bands. However, no consistent re-
gional changes were observed across the study
group as a whole.
(c) Concurrent EEG recording enabled us to estab-
lish that no seizures occurred in any of the pa-
tients during the period of tracer uptake.
(iii) SPECT findings
To enable comparison of results across subjects,
within each subject the activity (mean counts per
pixel) in each ROI was calculated as a ratio to activity
in a control area consisting of the occipital cortex bi-
laterally. The mean ratios across the subjects for each
ROI in each condition are given in Table 2. It was
found that in both left and right medial thalamic re-
gions there were significant decreases in activity asso-
ciated with rapid-cycling VNS.
Within the small sample studied, given that only two
of the seven subjects were non-responders, it was not
possible to statistically compare responder with re-
spect to non-responder SPECT data.
Although the mean thalamic ROI activity was sig-
nificantly different between the stimulation and the
comparison periods (Table 2), both values were within
the normal range. This normal range, measured using
the same equipment as was employed in the present
study, had previously been determined in 40 normal
controls. In the right thalamus the normal range (de-
fined as mean ± two standard deviations) was 0.80–
1.0 and in the left thalamus the normal range was
0.79–1.03.
Table 2: Mean ratios of region of interest activities over occip-
ital cortex activity in stimulation and comparison states.
Region Condition Mean activity/ Standard
visual cortex error
Left medial thalamusa Stimulation 0.851 0.03
Comparison 0.899 0.03
Right medial thalamusb Stimulation 0.814 0.05
Comparison 0.923 0.06
Left pulvinar Stimulation 0.853 0.05
Comparison 0.776 0.05
Right Pulvinar Stimulation 0.802 0.07
Comparison 0.856 0.05
Left insula Stimulation 0.869 0.03
Comparison 0.899 0.02
Right insula Stimulation 0.856 0.03
Comparison 0.894 0.03
Repeated measures analysis of variance (df. 6,1).
a (F = 7.86) P = 0.03; b (F = 18.6) P = 0.005.
DISCUSSION
The vagal nerve, through projections from the nu-
cleus of the tractus solitarius, has a diffuse projec-
tion within the brain. Amongst these are strong pro-
jections, through the parabrachial nucleus, to the tha-
lamus and then to the insular cortex. There is evidence
that the anterior nuclei of the thalamus and their asso-
ciated efferents and afferents are an important prop-
agation pathway in an animal model of generalized
tonic–clonic seizures, with a role in the propagation
of seizure activity from subcortex to cortex5. It was
on the basis of these observations that we limited our
analysis of SPECT regions to medial thalamic, pulv-
inar and anterior insular regions.
Our results indicate that rapid-cycling VNS was as-
sociated with significantly decreased activity in the
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left and right medial thalamus. No changes in activ-
ity (increases or decreases) were observed in anterior
insula or pulvinar regions. Whilst VNS was associated
with a relative hypoactivity, nevertheless, activity of
the thalamus during both the comparison and the ex-
perimental states remained within normal limits. This
may imply either that overall only a small reduction in
activity was noted, or that there was a more localized
and larger reduction in activity limited to a region, or
nucleus, below the resolution of the imaging system
employed. The relative thalamic hypoactivity was not
associated with changes in the insula, despite strong
connections between these regions. This indicates that
in the current study VNS is not in general associated
with changes in activity across all the target sites of
thalamic projections. It has been reported that experi-
mental inhibition of the nucleus tractus solitarius is an-
ticonvulsant8, as is activation of the locus coeruleus11,
and it is possible that the reduction in thalamic activity
observed in association with VNS in the current study
may be related to undetected changes in such regions
in our patients.
Several functional imaging studies of VNS in pa-
tients have recently been reported. The only other
SPECT study, using in that case 99mTc-ECD as the
tracer, reported decreased left thalamic activity12 in
10 patients, a finding also noted in our own study. Two
H2 15O PET studies have observed, amongst other
findings, increased thalamic activity. Ko et al.13 re-
ported right thalamic hyperactivity in three patients
whilst Henry et al.14 observed bilateral VNS-related
thalamic hyperactivity in 11 patients. Thus all stud-
ies currently reported have noted changes in thalamic
activity in association with VNS, although the direc-
tion of the changes vary. This variation may arise out
of differences between SPECT and PET techniques,
although such a systematic difference between these
investigative modalities has not been previously re-
ported and no possible mechanism that could under-
lie it has been described. Alternatively, the differences
in direction of thalamic change may be related to dif-
ferences between the study groups including; duration
of VNS treatment prior to scanning, the stimulation
paradigm used prior to and during scanning, the nature
of the epilepsy experienced by the patients, concomi-
tant and previous antiepileptic treatments, or patients’
individual responsivity to stimulation.
In the studies of both Henry14 and Van Laere12, pa-
tients were scanned before and just after initial switch-
ing on of the stimulator. In our own study the subjects
had been undergoing regular stimulation for at least
6 months. Hence whilst the former two studied exam-
ined the acute effects of stimulation, we were investi-
gating changes associated with a period of stimulation
following a period of chronic treatment. Although it
might have been suggested that we would not expect
to observe changes in cerebral activity associated with
brief on–off switches in stimulation after months of
regular stimulation, two clinical observations suggest
that even after months of stimulation, brain responses
to it are not fixed. The first is that after months or years
of VNS some patients are still able to abort a seizure
by acutely triggering a period of stimulation using the
magnet provided with the stimulator for that purpose.
Secondly, there is evidence from long-term studies15
that the treatment remains effective and indeed that ef-
ficacy tends to improve over at least the first 2 years
of treatment16. Hence it may be considered that this
study demonstrates the effects of acute VNS against a
background of chronic use. The clinical relevance of
this is that it is the situation that pertains in routine
clinical use.
The thalamic regions of interest in this study were
reasonably small; in the order of 2 cm diameter. Hence
it is possible that blood flow in these small regions
may have been underestimated because of partial vol-
ume effects. However, this is unlikely to have affected
the results since, firstly, we were comparing the same
structure in two different conditions, and secondly, the
control values for thalamic activity against which we
also compared our data were measured using the same
equipment and technical approach.
This study did not examine a wide range of cerebral
regions. However, the demonstration that activity was
only decreased in medial thalamic regions, but not in
thalamic pulvinar or insular regions suggests that the
changes observed were relatively specific and not sim-
ply part of a global difference in cerebral activity be-
tween the two conditions.
CONCLUSION
Whilst EEG studies have not detected clear VNS-
related changes in brain activity, one study suggests
that VNS effects on thalamic activity may mediate at
least some of the antiseizure effects of VNS14. The re-
sults of the current study, together with other blood-
flow imaging investigations12–14, appear to indicate
that VNS does lead to detectable changes in thalamic
activity.
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